Article Text
PDFReviews
Alzheimer's disease: mimics and chameleons
Statistics from Altmetric.com
Footnotes
-
Contributors Both authors contributed to the writing of this paper.
-
Funding This work was supported by the National Institute for Health Research (NIHR) Biomedical Research unit in Dementia based at University College London Hospitals (UCLH) and University College London (UCL). The views expressed by the authors are not necessarily those of the NHS, NIHR or the Department of Health. Dr Schott is a HEFCE Clinical Senior Lecturer and receives funding from Alzheimer's Research UK and the Alzheimer's Society. Dr Warren is in receipt of a Wellcome Trust Senior Clinical Fellowship (Grant No. 091673/Z/10/Z).
-
Competing interest None.
-
Provenance and peer review Commissioned, externally reviewed.
Linked Articles
- Editors' choice
Read the full text or download the PDF:
Other content recommended for you
- Biomarkers in dementia: clinical utility and new directions
- Dementia
- Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease
- An algorithmic approach to structural imaging in dementia
- Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage
- Presenile dementia syndromes: an update on taxonomy and diagnosis
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- Brain imaging in dementia
- Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
- Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis